CorMedix Inc CRMD

7.85 0.08 1.03% as of 25 Sep
Market cap
$608.0M
P/E
3.3×
Insider Buys alert about insiders buying in the last 12 month
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 — 0.00 5.26
P/S ratio
289.71 88.72 267.37 620.64 887.19 897.28 2,574.09 — 10.96 2.69
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 — 0.00 4.85
P/Operating CF
(9.99) (4.02) (15.96) (45.26) (35.77) (29.20) (27.35) — (84.93) 8.87
P/B ratio
3.64 4.06 23.29 7.44 4.80 2.73 3.06 — 5.63 2.07
Price to Tangible BV
3.64 4.06 23.29 7.44 4.80 2.73 3.06 — 5.76 0.00
EV/Sales
198.96 51.82 240.22 519.95 696.40 558.04 1,683.43 — 9.79 2.68
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 — 0.00 5.04
EV/Operating CF
(2.00) (0.60) (4.36) (9.79) (7.58) (5.04) (4.52) — (8.41) 4.76
EV/FCF
(2.00) (0.59) (4.35) (9.76) (7.54) (4.72) (4.48) — (8.39) 4.83
Quick Ratio
4.97 1.95 2.29 4.90 11.19 12.28 9.34 6.68 3.05 1.83
Current Ratio
5.34 2.12 2.40 5.04 11.58 12.44 9.44 6.97 3.39 2.11
Net Debt/EBITDA
0.82 0.37 0.44 1.38 1.69 2.21 1.92 1.56 2.36 (0.02)
Debt/Assets
0.00% 0.00% 32.54% 0.01% 1.87% 1.16% 1.08% 0.00% 0.00% 17.58%
Debt/Equity
0.00 0.00 1.24 0.00 0.02 0.01 0.01 0.00 0.00 0.36
Asset Turnover
0.01 0.02 0.03 0.01 0.01 0.00 0.00 0.00 0.43 0.66
Operating CF/Net income
0.90 0.87 0.88 0.35 1.00 0.75 0.82 0.83 2.82 1.07
Capex/Depreciation
(2.29) (4.12) (0.66) (0.09) (0.69) (8.05) (1.05) (1.59) (0.25) (0.15)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(95.10%) (264.01%) (442.49%) (304.66%) (64.91%) (52.72%) (50.40%) (74.02%) (23.17%) 66.56%
ROA
(83.53%) (186.71%) (166.23%) (180.27%) (55.92%) (47.71%) (45.35%) (64.32%) (17.85%) 34.51%
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% (42.38%) 23.34%
Return on Tangible Assets
(138.37%) (458.89%) (242.59%) (184.13%) (49.91%) (45.07%) (54.15%) (66.28%) (21.72%) 82.04%
Average Days of Receivables
19.54 71.05 9.26 0.00 5.19 86.80 0.00 — 433.70 200.51
Research and Development Expense of Revenue
7,021.55% 7,435.80% 4,379.36% 3,901.48% 5,592.47% 6,879.52% 16,329.66% 0.00% 9.07% 6.20%
Selling, General and Administrative Expense of Revenue
3,963.90% 2,627.51% 1,878.71% 3,482.17% 5,801.80% 8,562.91% 30,590.37% 0.00% 135.02% 34.09%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.50
Share Based Compensation of Revenue
595.81% 503.83% 258.40% 861.14% 1,045.07% 2,641.49% 6,222.48% 0.00% 14.10% 4.44%
Graham Net Nets
0.27 0.24 0.04 0.13 0.20 0.35 0.31 — 0.17 (0.06)
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 — 0.00 16.73
Earnings Yield
(37.43%) (115.09%) (25.58%) (9.33%) (10.23%) (16.26%) (17.70%) — (4.07%) 19.00%
Free Cash Flow Yield
(34.39%) (98.34%) (20.67%) (8.58%) (10.40%) (13.18%) (14.60%) — (10.64%) 20.62%
Revenue per Share
0.03 0.03 0.02 0.01 0.01 0.01 0.00 0.00 0.74 4.33
Operating CF per Share
(2.93) (2.59) (1.33) (0.62) (0.77) (0.56) (0.60) (0.75) (0.86) 2.43
Capex per Share
(0.01) (0.01) 0.00 0.00 0.00 (0.04) (0.01) (0.01) 0.00 (0.03)
Free Cash Flow per Share
(2.94) (2.61) (1.33) (0.62) (0.77) (0.60) (0.61) (0.76) (0.86) 2.40
Cash per Share
2.68 1.10 1.00 1.18 1.63 1.74 1.46 1.50 0.88 2.06
Shareholders Equity per Share
2.35 0.65 0.28 0.98 1.55 1.67 1.37 1.38 1.44 5.63
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
2.35 0.65 0.28 0.98 1.55 1.67 1.37 1.38 1.44 5.63
Free Cash Flow
(22.32) (28.74) (23.75) (15.09) (22.08) (22.58) (24.58) (38.74) (50.73) 172.79
Working Capital
17.74 7.01 10.90 23.52 44.02 61.12 53.24 68.05 80.74 192.78
Capital Expenditures
(0.06) (0.15) (0.05) (0.04) (0.11) (1.43) (0.22) (0.33) (0.12) (2.26)
Net Current Asset Value
17.74 7.01 4.77 23.52 43.10 60.32 52.57 67.53 80.39 (53.78)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 — 0.00 5.55
Capex to Sales
0.26 0.46 0.11 0.13 0.47 7.47 3.35 0.00 0.00 0.01
Net Profit Margin
(10,996.70%) (10,024.26%) (6,242.35%) (15,367.35%) (9,208.90%) (14,777.48%) (45,415.44%) 0.00% (41.24%) 52.31%
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 — 0.00 5.58
Other line items
Depreciation/Fixed assets
0.37 0.20 0.46 3.16 1.46 0.12 0.13 0.11 0.25 2.58
Cash ROIC
(58.54%) (148.71%) (82.69%) (29.08%) (24.08%) (17.52%) (22.65%) (27.54%) (38.46%) 24.19%
Accounts Receivable Turnover
1.37 8.65 11.46 51.98 140.71 7.82 0.00 — 1.68 2.80
Accounts Payable Turnover
0.22 0.07 0.18 0.21 0.19 0.09 0.00 0.00 1.06 7.49
Inventory Turnover
1.35 0.30 0.78 0.97 0.85 2.03 0.00 0.00 0.66 1.93
Average Days of Payables
1,637.67 5,739.39 2,381.51 1,001.79 2,010.53 5,416.41 217,234.19 0.00 196.80 80.02
Days of Inventory on Hand
165.93 1,885.94 394.16 331.06 255.93 7.35 0.00 0.00 869.59 301.61
Average Receivables
0.16 0.04 0.04 0.01 0.00 0.02 — — 25.85 111.44
Average Payables
1.68 1.73 2.20 1.81 1.08 1.67 2.21 3.24 3.00 4.80
Average Inventory
0.27 0.38 0.51 0.38 0.24 0.07 — 1.05 4.85 18.66
Average Assets
29.50 17.68 16.14 24.15 39.39 59.13 65.49 72.05 100.45 472.49
Average Common Equity
25.91 12.50 6.06 14.29 33.93 53.51 58.93 62.60 77.40 244.98

Fold the line items

Columns are period end dates